Skip to main content
PMC home page
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1994 Apr;70(822):257–274. doi: 10.1136/pgmj.70.822.257

Recent advances in cardiology.

C S Lawson 1, D J Coltart 1
PMCID: PMC2397878  PMID: 8183771

Full text

PDF
257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Adelman A. G., Cohen E. A., Kimball B. P., Bonan R., Ricci D. R., Webb J. G., Laramee L., Barbeau G., Traboulsi M., Corbett B. N. A comparison of directional atherectomy with balloon angioplasty for lesions of the left anterior descending coronary artery. N Engl J Med. 1993 Jul 22;329(4):228–233. doi: 10.1056/NEJM199307223290402. [DOI] [PubMed] [Google Scholar]
  2. Alpert M. A., Curtis J. J., Sanfelippo J. F., Flaker G. C., Walls J. T., Mukerji V., Villarreal D., Katti S. K., Madigan N. P., Krol R. B. Comparative survival after permanent ventricular and dual chamber pacing for patients with chronic high degree atrioventricular block with and without preexistent congestive heart failure. J Am Coll Cardiol. 1986 Apr;7(4):925–932. doi: 10.1016/s0735-1097(86)80358-8. [DOI] [PubMed] [Google Scholar]
  3. Anjos R., Qureshi S. A., Rosenthal E., Murdoch I., Hayes A., Parsons J., Baker E. J., Tynan M. Determinants of hemodynamic results of balloon dilation of aortic recoarctation. Am J Cardiol. 1992 Mar 1;69(6):665–671. doi: 10.1016/0002-9149(92)90161-q. [DOI] [PubMed] [Google Scholar]
  4. Ballal R. S., Nanda N. C., Gatewood R., D'Arcy B., Samdarshi T. E., Holman W. L., Kirklin J. K., Pacifico A. D. Usefulness of transesophageal echocardiography in assessment of aortic dissection. Circulation. 1991 Nov;84(5):1903–1914. doi: 10.1161/01.cir.84.5.1903. [DOI] [PubMed] [Google Scholar]
  5. Barker D. J. Fetal origins of coronary heart disease. Br Heart J. 1993 Mar;69(3):195–196. doi: 10.1136/hrt.69.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Barker D. J., Winter P. D., Osmond C., Margetts B., Simmonds S. J. Weight in infancy and death from ischaemic heart disease. Lancet. 1989 Sep 9;2(8663):577–580. doi: 10.1016/s0140-6736(89)90710-1. [DOI] [PubMed] [Google Scholar]
  7. Bernard Y., Etievent J., Mourand J. L., Anguenot T., Schiele F., Guseibat M., Bassand J. P. Long-term results of percutaneous aortic valvuloplasty compared with aortic valve replacement in patients more than 75 years old. J Am Coll Cardiol. 1992 Oct;20(4):796–801. doi: 10.1016/0735-1097(92)90174-l. [DOI] [PubMed] [Google Scholar]
  8. Brown G., Albers J. J., Fisher L. D., Schaefer S. M., Lin J. T., Kaplan C., Zhao X. Q., Bisson B. D., Fitzpatrick V. F., Dodge H. T. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med. 1990 Nov 8;323(19):1289–1298. doi: 10.1056/NEJM199011083231901. [DOI] [PubMed] [Google Scholar]
  9. Calkins H., Sousa J., el-Atassi R., Rosenheck S., de Buitleir M., Kou W. H., Kadish A. H., Langberg J. J., Morady F. Diagnosis and cure of the Wolff-Parkinson-White syndrome or paroxysmal supraventricular tachycardias during a single electrophysiologic test. N Engl J Med. 1991 Jun 6;324(23):1612–1618. doi: 10.1056/NEJM199106063242302. [DOI] [PubMed] [Google Scholar]
  10. Cashin-Hemphill L., Mack W. J., Pogoda J. M., Sanmarco M. E., Azen S. P., Blankenhorn D. H. Beneficial effects of colestipol-niacin on coronary atherosclerosis. A 4-year follow-up. JAMA. 1990 Dec 19;264(23):3013–3017. [PubMed] [Google Scholar]
  11. Cohen M. V., Liu G. S., Downey J. M. Preconditioning causes improved wall motion as well as smaller infarcts after transient coronary occlusion in rabbits. Circulation. 1991 Jul;84(1):341–349. doi: 10.1161/01.cir.84.1.341. [DOI] [PubMed] [Google Scholar]
  12. Cohn J. N., Archibald D. G., Ziesche S., Franciosa J. A., Harston W. E., Tristani F. E., Dunkman W. B., Jacobs W., Francis G. S., Flohr K. H. Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study. N Engl J Med. 1986 Jun 12;314(24):1547–1552. doi: 10.1056/NEJM198606123142404. [DOI] [PubMed] [Google Scholar]
  13. Cohn J. N., Johnson G., Ziesche S., Cobb F., Francis G., Tristani F., Smith R., Dunkman W. B., Loeb H., Wong M. A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure. N Engl J Med. 1991 Aug 1;325(5):303–310. doi: 10.1056/NEJM199108013250502. [DOI] [PubMed] [Google Scholar]
  14. Connolly S. J., Laupacis A., Gent M., Roberts R. S., Cairns J. A., Joyner C. Canadian Atrial Fibrillation Anticoagulation (CAFA) Study. J Am Coll Cardiol. 1991 Aug;18(2):349–355. doi: 10.1016/0735-1097(91)90585-w. [DOI] [PubMed] [Google Scholar]
  15. Cox J. L., Boineau J. P., Schuessler R. B., Ferguson T. B., Jr, Cain M. E., Lindsay B. D., Corr P. B., Kater K. M., Lappas D. G. Operations for atrial fibrillation. Clin Cardiol. 1991 Oct;14(10):827–834. doi: 10.1002/clc.4960141010. [DOI] [PubMed] [Google Scholar]
  16. Daniel W. G., Mügge A., Martin R. P., Lindert O., Hausmann D., Nonnast-Daniel B., Laas J., Lichtlen P. R. Improvement in the diagnosis of abscesses associated with endocarditis by transesophageal echocardiography. N Engl J Med. 1991 Mar 21;324(12):795–800. doi: 10.1056/NEJM199103213241203. [DOI] [PubMed] [Google Scholar]
  17. Davey Smith G., Pekkanen J. Should there be a moratorium on the use of cholesterol lowering drugs? BMJ. 1992 Feb 15;304(6824):431–434. doi: 10.1136/bmj.304.6824.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Davies M. J., Ward D. E. How can myocarditis be diagnosed and should it be treated? Br Heart J. 1992 Oct;68(4):346–347. doi: 10.1136/hrt.68.10.346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Deutsch E., Berger M., Kussmaul W. G., Hirshfeld J. W., Jr, Herrmann H. C., Laskey W. K. Adaptation to ischemia during percutaneous transluminal coronary angioplasty. Clinical, hemodynamic, and metabolic features. Circulation. 1990 Dec;82(6):2044–2051. doi: 10.1161/01.cir.82.6.2044. [DOI] [PubMed] [Google Scholar]
  20. Eigler N. L., Weinstock B., Douglas J. S., Jr, Goldenberg T., Hartzler G., Holmes D., Leon M., Margolis J., Nobuyoshi M., O'Neill W. Excimer laser coronary angioplasty of aorto-ostial stenoses. Results of the excimer laser coronary angioplasty (ELCA) registry in the first 200 patients. Circulation. 1993 Nov;88(5 Pt 1):2049–2057. doi: 10.1161/01.cir.88.5.2049. [DOI] [PubMed] [Google Scholar]
  21. Ezekowitz M. D., Bridgers S. L., James K. E., Carliner N. H., Colling C. L., Gornick C. C., Krause-Steinrauf H., Kurtzke J. F., Nazarian S. M., Radford M. J. Warfarin in the prevention of stroke associated with nonrheumatic atrial fibrillation. Veterans Affairs Stroke Prevention in Nonrheumatic Atrial Fibrillation Investigators. N Engl J Med. 1992 Nov 12;327(20):1406–1412. doi: 10.1056/NEJM199211123272002. [DOI] [PubMed] [Google Scholar]
  22. Fananapazir L., Cannon R. O., 3rd, Tripodi D., Panza J. A. Impact of dual-chamber permanent pacing in patients with obstructive hypertrophic cardiomyopathy with symptoms refractory to verapamil and beta-adrenergic blocker therapy. Circulation. 1992 Jun;85(6):2149–2161. doi: 10.1161/01.cir.85.6.2149. [DOI] [PubMed] [Google Scholar]
  23. Feldman A. M., Bristow M. R., Parmley W. W., Carson P. E., Pepine C. J., Gilbert E. M., Strobeck J. E., Hendrix G. H., Powers E. R., Bain R. P. Effects of vesnarinone on morbidity and mortality in patients with heart failure. Vesnarinone Study Group. N Engl J Med. 1993 Jul 15;329(3):149–155. doi: 10.1056/NEJM199307153290301. [DOI] [PubMed] [Google Scholar]
  24. Fogoros R. N., Elson J. J., Bonnet C. A., Fiedler S. B., Chenarides J. G. Long-term outcome of survivors of cardiac arrest whose therapy is guided by electrophysiologic testing. J Am Coll Cardiol. 1992 Mar 15;19(4):780–788. doi: 10.1016/0735-1097(92)90518-r. [DOI] [PubMed] [Google Scholar]
  25. Fontes V. F., Sousa J. E., Esteves C. A., Silva M. V., Cano M. N., Maldonado G. Pulmonary valvoplasty--experience of 100 cases. Int J Cardiol. 1988 Dec;21(3):335–342. doi: 10.1016/0167-5273(88)90110-6. [DOI] [PubMed] [Google Scholar]
  26. Geisterfer-Lowrance A. A., Kass S., Tanigawa G., Vosberg H. P., McKenna W., Seidman C. E., Seidman J. G. A molecular basis for familial hypertrophic cardiomyopathy: a beta cardiac myosin heavy chain gene missense mutation. Cell. 1990 Sep 7;62(5):999–1006. doi: 10.1016/0092-8674(90)90274-i. [DOI] [PubMed] [Google Scholar]
  27. Gibbons R. J., Holmes D. R., Reeder G. S., Bailey K. R., Hopfenspirger M. R., Gersh B. J. Immediate angioplasty compared with the administration of a thrombolytic agent followed by conservative treatment for myocardial infarction. The Mayo Coronary Care Unit and Catheterization Laboratory Groups. N Engl J Med. 1993 Mar 11;328(10):685–691. doi: 10.1056/NEJM199303113281003. [DOI] [PubMed] [Google Scholar]
  28. Goy J. J., Sigwart U., Vogt P., Stauffer J. C., Kaufmann U., Urban P., Kappenberger L. Long-term follow-up of the first 56 patients treated with intracoronary self-expanding stents (the Lausanne experience). Am J Cardiol. 1991 Mar 15;67(7):569–572. doi: 10.1016/0002-9149(91)90893-p. [DOI] [PubMed] [Google Scholar]
  29. Gray D. T., Fyler D. C., Walker A. M., Weinstein M. C., Chalmers T. C. Clinical outcomes and costs of transcatheter as compared with surgical closure of patent ductus arteriosus. The Patient Ductus Arteriosus Closure Comparative Study Group. N Engl J Med. 1993 Nov 18;329(21):1517–1523. doi: 10.1056/NEJM199311183292101. [DOI] [PubMed] [Google Scholar]
  30. Greene H. L., Roden D. M., Katz R. J., Woosley R. L., Salerno D. M., Henthorn R. W. The Cardiac Arrhythmia Suppression Trial: first CAST ... then CAST-II. J Am Coll Cardiol. 1992 Apr;19(5):894–898. doi: 10.1016/0735-1097(92)90267-q. [DOI] [PubMed] [Google Scholar]
  31. Grines C. L., Browne K. F., Marco J., Rothbaum D., Stone G. W., O'Keefe J., Overlie P., Donohue B., Chelliah N., Timmis G. C. A comparison of immediate angioplasty with thrombolytic therapy for acute myocardial infarction. The Primary Angioplasty in Myocardial Infarction Study Group. N Engl J Med. 1993 Mar 11;328(10):673–679. doi: 10.1056/NEJM199303113281001. [DOI] [PubMed] [Google Scholar]
  32. Hearn J. A., King S. B., 3rd, Douglas J. S., Jr, Carlin S. F., Lembo N. J., Ghazzal Z. M. Clinical and angiographic outcomes after coronary artery stenting for acute or threatened closure after percutaneous transluminal coronary angioplasty. Initial results with a balloon-expandable, stainless steel design. Circulation. 1993 Nov;88(5 Pt 1):2086–2096. doi: 10.1161/01.cir.88.5.2086. [DOI] [PubMed] [Google Scholar]
  33. Hodgson J. M., Marshall J. J. Direct vasoconstriction and endothelium-dependent vasodilation. Mechanisms of acetylcholine effects on coronary flow and arterial diameter in patients with nonstenotic coronary arteries. Circulation. 1989 May;79(5):1043–1051. doi: 10.1161/01.cir.79.5.1043. [DOI] [PubMed] [Google Scholar]
  34. Inoue A., Yanagisawa M., Kimura S., Kasuya Y., Miyauchi T., Goto K., Masaki T. The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A. 1989 Apr;86(8):2863–2867. doi: 10.1073/pnas.86.8.2863. [DOI] [PMC free article] [PubMed] [Google Scholar]
  35. Jackman W. M., Wang X. Z., Friday K. J., Roman C. A., Moulton K. P., Beckman K. J., McClelland J. H., Twidale N., Hazlitt H. A., Prior M. I. Catheter ablation of accessory atrioventricular pathways (Wolff-Parkinson-White syndrome) by radiofrequency current. N Engl J Med. 1991 Jun 6;324(23):1605–1611. doi: 10.1056/NEJM199106063242301. [DOI] [PubMed] [Google Scholar]
  36. Jeanrenaud X., Goy J. J., Kappenberger L. Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet. 1992 May 30;339(8805):1318–1323. doi: 10.1016/0140-6736(92)91961-7. [DOI] [PubMed] [Google Scholar]
  37. Juul-Möller S., Edvardsson N., Jahnmatz B., Rosén A., Sørensen S., Omblus R. Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin Trial (SAPAT) Group. Lancet. 1992 Dec 12;340(8833):1421–1425. doi: 10.1016/0140-6736(92)92619-q. [DOI] [PubMed] [Google Scholar]
  38. Keating M., Atkinson D., Dunn C., Timothy K., Vincent G. M., Leppert M. Linkage of a cardiac arrhythmia, the long QT syndrome, and the Harvey ras-1 gene. Science. 1991 May 3;252(5006):704–706. doi: 10.1126/science.1673802. [DOI] [PubMed] [Google Scholar]
  39. Late Assessment of Thrombolytic Efficacy (LATE) study with alteplase 6-24 hours after onset of acute myocardial infarction. Lancet. 1993 Sep 25;342(8874):759–766. [PubMed] [Google Scholar]
  40. Lesh M. D., Van Hare G. F., Schamp D. J., Chien W., Lee M. A., Griffin J. C., Langberg J. J., Cohen T. J., Lurie K. G., Scheinman M. M. Curative percutaneous catheter ablation using radiofrequency energy for accessory pathways in all locations: results in 100 consecutive patients. J Am Coll Cardiol. 1992 May;19(6):1303–1309. doi: 10.1016/0735-1097(92)90338-n. [DOI] [PubMed] [Google Scholar]
  41. Ludman P. F., Poole-Wilson P. A. Myocardial perfusion in humans: what can we measure? Br Heart J. 1993 Oct;70(4):307–314. doi: 10.1136/hrt.70.4.307. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Manning W. J., Li W., Edelman R. R. A preliminary report comparing magnetic resonance coronary angiography with conventional angiography. N Engl J Med. 1993 Mar 25;328(12):828–832. doi: 10.1056/NEJM199303253281202. [DOI] [PubMed] [Google Scholar]
  43. Manning W. J., Silverman D. I., Gordon S. P., Krumholz H. M., Douglas P. S. Cardioversion from atrial fibrillation without prolonged anticoagulation with use of transesophageal echocardiography to exclude the presence of atrial thrombi. N Engl J Med. 1993 Mar 18;328(11):750–755. doi: 10.1056/NEJM199303183281102. [DOI] [PubMed] [Google Scholar]
  44. Mason J. W. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators. N Engl J Med. 1993 Aug 12;329(7):445–451. doi: 10.1056/NEJM199308123290701. [DOI] [PubMed] [Google Scholar]
  45. Michels V. V., Moll P. P., Miller F. A., Tajik A. J., Chu J. S., Driscoll D. J., Burnett J. C., Rodeheffer R. J., Chesebro J. H., Tazelaar H. D. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med. 1992 Jan 9;326(2):77–82. doi: 10.1056/NEJM199201093260201. [DOI] [PubMed] [Google Scholar]
  46. Millane T. A., Camm A. J. Magnesium and the myocardium. Br Heart J. 1992 Nov;68(5):441–442. doi: 10.1136/hrt.68.11.441. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Muntoni F., Cau M., Ganau A., Congiu R., Arvedi G., Mateddu A., Marrosu M. G., Cianchetti C., Realdi G., Cao A. Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N Engl J Med. 1993 Sep 23;329(13):921–925. doi: 10.1056/NEJM199309233291304. [DOI] [PubMed] [Google Scholar]
  48. Murry C. E., Jennings R. B., Reimer K. A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium. Circulation. 1986 Nov;74(5):1124–1136. doi: 10.1161/01.cir.74.5.1124. [DOI] [PubMed] [Google Scholar]
  49. Nathan A. W., Davies D. W. Is VVI pacing outmoded? Br Heart J. 1992 Apr;67(4):285–288. doi: 10.1136/hrt.67.4.285. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Packer M., Narahara K. A., Elkayam U., Sullivan J. M., Pearle D. L., Massie B. M., Creager M. A. Double-blind, placebo-controlled study of the efficacy of flosequinan in patients with chronic heart failure. Principal Investigators of the REFLECT Study. J Am Coll Cardiol. 1993 Jul;22(1):65–72. doi: 10.1016/0735-1097(93)90816-j. [DOI] [PubMed] [Google Scholar]
  51. Palmer R. M., Ferrige A. G., Moncada S. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature. 1987 Jun 11;327(6122):524–526. doi: 10.1038/327524a0. [DOI] [PubMed] [Google Scholar]
  52. Parisi A. F., Folland E. D., Hartigan P. A comparison of angioplasty with medical therapy in the treatment of single-vessel coronary artery disease. Veterans Affairs ACME Investigators. N Engl J Med. 1992 Jan 2;326(1):10–16. doi: 10.1056/NEJM199201023260102. [DOI] [PubMed] [Google Scholar]
  53. Petch M. C. Who needs dual chamber pacing? BMJ. 1993 Jul 24;307(6898):215–216. doi: 10.1136/bmj.307.6898.215. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Petersen P., Boysen G., Godtfredsen J., Andersen E. D., Andersen B. Placebo-controlled, randomised trial of warfarin and aspirin for prevention of thromboembolic complications in chronic atrial fibrillation. The Copenhagen AFASAK study. Lancet. 1989 Jan 28;1(8631):175–179. doi: 10.1016/s0140-6736(89)91200-2. [DOI] [PubMed] [Google Scholar]
  55. Petros A., Bennett D., Vallance P. Effect of nitric oxide synthase inhibitors on hypotension in patients with septic shock. Lancet. 1991 Dec 21;338(8782-8783):1557–1558. doi: 10.1016/0140-6736(91)92376-d. [DOI] [PubMed] [Google Scholar]
  56. Pfeffer M. A., Braunwald E., Moyé L. A., Basta L., Brown E. J., Jr, Cuddy T. E., Davis B. R., Geltman E. M., Goldman S., Flaker G. C. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. N Engl J Med. 1992 Sep 3;327(10):669–677. doi: 10.1056/NEJM199209033271001. [DOI] [PubMed] [Google Scholar]
  57. Randomised trial of late thrombolysis in patients with suspected acute myocardial infarction. EMERAS (Estudio Multicéntrico Estreptoquinasa Repúblicas de América del Sur) Collaborative Group. Lancet. 1993 Sep 25;342(8874):767–772. [PubMed] [Google Scholar]
  58. Rankin A. C., Oldroyd K. G., Chong E., Rae A. P., Cobbe S. M. Value and limitations of adenosine in the diagnosis and treatment of narrow and broad complex tachycardias. Br Heart J. 1989 Sep;62(3):195–203. doi: 10.1136/hrt.62.3.195. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Rocchini A. P., Beekman R. H., Ben Shachar G., Benson L., Schwartz D., Kan J. S. Balloon aortic valvuloplasty: results of the Valvuloplasty and Angioplasty of Congenital Anomalies Registry. Am J Cardiol. 1990 Mar 15;65(11):784–789. doi: 10.1016/0002-9149(90)91388-m. [DOI] [PubMed] [Google Scholar]
  60. Schatz R. A., Baim D. S., Leon M., Ellis S. G., Goldberg S., Hirshfeld J. W., Cleman M. W., Cabin H. S., Walker C., Stagg J. Clinical experience with the Palmaz-Schatz coronary stent. Initial results of a multicenter study. Circulation. 1991 Jan;83(1):148–161. doi: 10.1161/01.cir.83.1.148. [DOI] [PubMed] [Google Scholar]
  61. Schelbert H. R., Stevenson L. W. Toward an improved understanding and management of human heart transplant recipients. J Am Coll Cardiol. 1992 Jan;19(1):107–109. doi: 10.1016/0735-1097(92)90059-v. [DOI] [PubMed] [Google Scholar]
  62. Shakespeare C. F., Coltart D. J. Recent advances in cardiology. Postgrad Med J. 1992 May;68(799):327–337. doi: 10.1136/pgmj.68.799.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
  63. Shiki K., Hearse D. J. Preconditioning of ischemic myocardium: reperfusion-induced arrhythmias. Am J Physiol. 1987 Dec;253(6 Pt 2):H1470–H1476. doi: 10.1152/ajpheart.1987.253.6.H1470. [DOI] [PubMed] [Google Scholar]
  64. Shively B. K., Gurule F. T., Roldan C. A., Leggett J. H., Schiller N. B. Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis. J Am Coll Cardiol. 1991 Aug;18(2):391–397. doi: 10.1016/0735-1097(91)90591-v. [DOI] [PubMed] [Google Scholar]
  65. Solomon S. D., Jarcho J. A., McKenna W., Geisterfer-Lowrance A., Germain R., Salerni R., Seidman J. G., Seidman C. E. Familial hypertrophic cardiomyopathy is a genetically heterogeneous disease. J Clin Invest. 1990 Sep;86(3):993–999. doi: 10.1172/JCI114802. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Sra J. S., Jazayeri M. R., Avitall B., Dhala A., Deshpande S., Blanck Z., Akhtar M. Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Engl J Med. 1993 Apr 15;328(15):1085–1090. doi: 10.1056/NEJM199304153281504. [DOI] [PubMed] [Google Scholar]
  67. Stevenson L. W., Miller L. W. Cardiac transplantation as therapy for heart failure. Curr Probl Cardiol. 1991 Apr;16(4):217–305. doi: 10.1016/0146-2806(91)90026-7. [DOI] [PubMed] [Google Scholar]
  68. Swedberg K., Held P., Kjekshus J., Rasmussen K., Rydén L., Wedel H. Effects of the early administration of enalapril on mortality in patients with acute myocardial infarction. Results of the Cooperative New Scandinavian Enalapril Survival Study II (CONSENSUS II) N Engl J Med. 1992 Sep 3;327(10):678–684. doi: 10.1056/NEJM199209033271002. [DOI] [PubMed] [Google Scholar]
  69. Topol E. J., Leya F., Pinkerton C. A., Whitlow P. L., Hofling B., Simonton C. A., Masden R. R., Serruys P. W., Leon M. B., Williams D. O. A comparison of directional atherectomy with coronary angioplasty in patients with coronary artery disease. The CAVEAT Study Group. N Engl J Med. 1993 Jul 22;329(4):221–227. doi: 10.1056/NEJM199307223290401. [DOI] [PubMed] [Google Scholar]
  70. Travill C. M., Sutton R. Pacemaker syndrome: an iatrogenic condition. Br Heart J. 1992 Aug;68(2):163–166. doi: 10.1136/hrt.68.8.163. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Uretsky B. F., Murali S., Reddy P. S., Rabin B., Lee A., Griffith B. P., Hardesty R. L., Trento A., Bahnson H. T. Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone. Circulation. 1987 Oct;76(4):827–834. doi: 10.1161/01.cir.76.4.827. [DOI] [PubMed] [Google Scholar]
  72. Uretsky B. F., Young J. B., Shahidi F. E., Yellen L. G., Harrison M. C., Jolly M. K. Randomized study assessing the effect of digoxin withdrawal in patients with mild to moderate chronic congestive heart failure: results of the PROVED trial. PROVED Investigative Group. J Am Coll Cardiol. 1993 Oct;22(4):955–962. doi: 10.1016/0735-1097(93)90403-n. [DOI] [PubMed] [Google Scholar]
  73. Waller B. F., Pinkerton C. A., Slack J. D. Intravascular ultrasound: a histological study of vessels during life. The new 'gold standard' for vascular imaging. Circulation. 1992 Jun;85(6):2305–2310. doi: 10.1161/01.cir.85.6.2305. [DOI] [PubMed] [Google Scholar]
  74. Watkins H., Seidman C. E., MacRae C., Seidman J. G., McKenna W. Progress in familial hypertrophic cardiomyopathy: molecular genetic analyses in the original family studied by Teare. Br Heart J. 1992 Jan;67(1):34–38. doi: 10.1136/hrt.67.1.34. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Watts G. F., Lewis B., Brunt J. N., Lewis E. S., Coltart D. J., Smith L. D., Mann J. I., Swan A. V. Effects on coronary artery disease of lipid-lowering diet, or diet plus cholestyramine, in the St Thomas' Atherosclerosis Regression Study (STARS) Lancet. 1992 Mar 7;339(8793):563–569. doi: 10.1016/0140-6736(92)90863-x. [DOI] [PubMed] [Google Scholar]
  76. Werns S. W., Walton J. A., Hsia H. H., Nabel E. G., Sanz M. L., Pitt B. Evidence of endothelial dysfunction in angiographically normal coronary arteries of patients with coronary artery disease. Circulation. 1989 Feb;79(2):287–291. doi: 10.1161/01.cir.79.2.287. [DOI] [PubMed] [Google Scholar]
  77. Williams D. O., Braunwald E., Knatterud G., Babb J., Bresnahan J., Greenberg M. A., Raizner A., Wasserman A., Robertson T., Ross R. One-year results of the Thrombolysis in Myocardial Infarction investigation (TIMI) Phase II Trial. Circulation. 1992 Feb;85(2):533–542. doi: 10.1161/01.cir.85.2.533. [DOI] [PubMed] [Google Scholar]
  78. Winkle R. A., Mead R. H., Ruder M. A., Gaudiani V. A., Smith N. A., Buch W. S., Schmidt P., Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989 May;13(6):1353–1361. doi: 10.1016/0735-1097(89)90310-0. [DOI] [PubMed] [Google Scholar]
  79. Woods K. L., Fletcher S., Roffe C., Haider Y. Intravenous magnesium sulphate in suspected acute myocardial infarction: results of the second Leicester Intravenous Magnesium Intervention Trial (LIMIT-2) Lancet. 1992 Jun 27;339(8809):1553–1558. doi: 10.1016/0140-6736(92)91828-v. [DOI] [PubMed] [Google Scholar]
  80. Wright C. E., Rees D. D., Moncada S. Protective and pathological roles of nitric oxide in endotoxin shock. Cardiovasc Res. 1992 Jan;26(1):48–57. doi: 10.1093/cvr/26.1.48. [DOI] [PubMed] [Google Scholar]
  81. Yellon D. M., Alkhulaifi A. M., Pugsley W. B. Preconditioning the human myocardium. Lancet. 1993 Jul 31;342(8866):276–277. doi: 10.1016/0140-6736(93)91819-8. [DOI] [PubMed] [Google Scholar]
  82. Zijlstra F., de Boer M. J., Hoorntje J. C., Reiffers S., Reiber J. H., Suryapranata H. A comparison of immediate coronary angioplasty with intravenous streptokinase in acute myocardial infarction. N Engl J Med. 1993 Mar 11;328(10):680–684. doi: 10.1056/NEJM199303113281002. [DOI] [PubMed] [Google Scholar]
  83. de Belder M. A., Linker N. J., Jones S., Camm A. J., Ward D. E. Cost implications of the British Pacing and Electrophysiology Group's recommendations for pacing. BMJ. 1992 Oct 10;305(6858):861–865. doi: 10.1136/bmj.305.6858.861. [DOI] [PMC free article] [PubMed] [Google Scholar]
  84. de Belder M. A., Tourikis L., Griffith M., Leech G., Camm A. J. Transesophageal contrast echocardiography and color flow mapping: methods of choice for the detection of shunts at the atrial level? Am Heart J. 1992 Dec;124(6):1545–1550. doi: 10.1016/0002-8703(92)90070-c. [DOI] [PubMed] [Google Scholar]
  85. de Feyter P. J., DeScheerder I., van den Brand M., Laarman G., Suryapranata H., Serruys P. W. Emergency stenting for refractory acute coronary artery occlusion during coronary angioplasty. Am J Cardiol. 1990 Nov 1;66(15):1147–1150. doi: 10.1016/0002-9149(90)90522-3. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES